Drug Development in Traumatic Brain Injury
Neal Farber PhD is on the Board of Governors for the International Brain Injury Association. IBIA recently published this article authored by Dr. Farber:
Developing drug treatments for traumatic brain injury (TBI) has been notoriously difficult. While most of the severe neural damage that accompanies acute TBI results from the initial impact, considerable additional damage occurs over the following hours and days by biochemical cascades triggering inflammation, cell death and disruption of neural pathways. It would be ideal to have a treatment that prevents this degeneration, but decades of clinical research have so far been unsuccessful. In addition, there are non-acute symptoms such as prolonged disorders of consciousness, long-term cognitive and physical impairments, for which treatments have not been developed. [full story]
The people at Titolo Law Office represent only those injured in car accidents, truck accidents, Death accidents, falls and most all injury accidents. Please give us a call at 702.869.5100 and find out how we can help you.
